|
INVESTOR INFORMATION
Total Health
Enhancement is pleased to announce it Hemoxide™ Infomercial.
Visit
www.healthyproduct.com
to learn more.
The Nutraceutical market represents one
of the greatest opportunities in Human and Animal health care
solutions. As the public becomes increasingly wary of the side effects
of Pharmaceuticals and Herbal Remedies turn out less effective than
hoped, the health conscious are turning to the newer technology of
Nutraceuticals.
Total Health Enhancement, Inc. (Total
Health) is uniquely positioned to take advantage of this opportunity.
With a range of effective products and the ability to expand into new
markets, Total Health is prepared to capitalize on this niche. Total
Health formulates products as a result of market need rather than what
they believe to be great products; thus providing products with a ready
demand. Then, using methodologies based on the proprietary
Neurotransmitter Production Support Technology (N.P.S.) and data
gathered from international medical literature, Total Health formulates
a product, designs and performs scientific studies to (biochemical,
physiologic, clinical, placebo controlled double blind trials) validate
this product.
Total Health has worked within the
Clinical Medical Foods environment for a number of years and has
recently begun to gain momentum for ‘Over-the-Counter’ products.
Concurrently, an opportunity within the Equine marketplace appeared
where product sales are gaining momentum. It is this market that Total
Health chose to target first due to the low barrier to entry for their
product; no lengthy efficacy trials as is the case with human products.
The principal
intellectual property of Total Health is “Neurotransmitter Production
Support” (N.P.S.), a ‘platform technology’ that allows common amino
acids, the building blocks of the body, to operate at doses 2%-5% of
what was previously thought possible. Amino acids are the ‘feedstocks’
from which the body produces neurotransmitters. Neurotransmitters
govern virtually all functions of the body. Therefore the N.P.S.
technology has immense potential in both human and animal nutrition as
well as disease treatment.
In the United States alone, there are
over 6.9 million horses and an $8 billion market products for equine
health. Total Health has a tremendous opportunity in this area. Total
Health has also ventured into developing similar products for dogs,
cats, livestock, and zoo animals.
 The human market potential is
significantly greater, but has higher product development and marketing
costs. Initial products developed for Humans have performed well beyond
expectations. The market in the United States for nutritional products
alone exceeds $52 billion.
One of Total Health’s unique advantages
is to identify a demand for a product and develop a marketable commodity
in a very short period of time. In the pharmaceutical industry it
typically takes over 7 years from the time a drug is formulated until it
is approved for animal use. Conventional approaches to developing a new
drug for animals cost tens of millions of dollars before it can be
offered for sale.
All existing
competitive products are more dangerous (particularly pharmaceuticals
using receptor technology), more expensive (because of the large
quantities of active elements required due to the absence of N.P.S.) or
less effective. In some cases (e.g.: serotonin production without
tryptophan) there is no known way to accomplish the effect without N.P.S.
patent protected elements. As long as Total Health’s N.P.S. system
remains protected Total Health has the opportunity to obtain and hold a
strong market share. |
